Reader View AI Reader View J&J in talks to buy eye disease biotech Ollin for $3.4 bln, FT reports www.investing.com · November 16, 2026 · 00:53 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link